LIGAND PHARMACEUTICALS INC

Company

LIGAND PHARMACEUTICALS INC

Filed

February 14, 2007

Accession Number

0000902664-07-000919

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →